Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 1, 2008, Pages 114-118

  Konski, Andre ^a   Garcia Jr , Miguel ^b   John, Madhu ^c   Krieg, Richard ^d   Pinover, Wayne ^e   Myerson, Robert ^f   Willett, Christopher ^g  

^a FOX CHASE CANCER CENTER   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c Cancer Center at St Agnes   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e ABINGTON MEMORIAL HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anal cancer; Chemoradiation; Mandatory treatment break

Indexed keywords

COMPUTER OPERATING SYSTEMS; ESTIMATION; RADIOTHERAPY; SHELTERS (FROM ATTACK); TESTING; TOXICITY; TUMORS;

ANAL CANCER; CHEMORADIATION; KAPLAN-MEIER METHOD; LOG-RANK TEST; MANDATORY TREATMENT BREAK; MITOMYCIN-C; OVERALL SURVIVAL; PHASE II; SAMPLE SIZES; TUMOR SIZE;

PATIENT TREATMENT;

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; COLOSTOMY; CONTROLLED STUDY; CUMULATIVE INCIDENCE METHOD; DISTANT METASTASIS; DRUG EFFICACY; EVALUATION; FEMALE; GASTROINTESTINAL TOXICITY; GRAY TEST; HUMAN; KAPLAN MEIER METHOD; LOCOREGIONAL FAILURE; LOG RANK TEST; MALE; MANDATORY TREATMENT BREAK; OVERALL SURVIVAL; PARAMETER; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; RADIATION THERAPY ONCOLOGY GROUP; SKIN TOXICITY; STATISTICAL ANALYSIS; TECHNIQUE; TREATMENT OUTCOME; TREATMENT PLANNING; UROGENITAL TRACT TOXICITY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; COLOSTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; RADIATION INJURIES;

EID: 49549119756     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.12.027     Document Type: Article

References (14)

1. John M., Pajak T., Flam M., et al. Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08. Cancer J Sci Am 2 (1996) 205-211
2. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
3. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J Am Stats Assoc 53 (1958) 447-457
4. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
5. Kalbfleisch J., and Prentice R.L. The statistical analysis of failure time data (1980), John Wiley & Sons, New York
6. Gray R. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1143
7. Cox D.R. Regression models and life tables. J Roy Stat Soc 34 (1972) 187-220
8. Weber D.C., Kurtz J.M., and Allal A.S. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 675-680
9. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
10. Cummings B.J., Keane T.J., O'Sullivan B., et al. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21 (1991) 1115-1125
11. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-flourouracil, and mitomycin. Lancet 348 (1996) 1049-1054
12. Allal A.S., Mermillod B., Roth A.D., et al. Impact of clinical and therapeutic factors on major late complications after radiotherapy with or without concomitant chemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 39 (1997) 1099-1105
13. Hung A., Crane C., Delclos M., et al. Cisplatin-based combined modality therapy for anal carcinoma: A wider therapeutic index. Cancer 97 (2003) 1195-1202
14. Withers H.R., Taylor J.M., and Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146